Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06SRX
|
||||
Former ID |
DIB016932
|
||||
Drug Name |
MDA-19
|
||||
Synonyms |
Cannabinoid CB2 agonist (neuropathic pain), MD Anderson Cancer Center
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Neuropathic pain [ICD9: 356.0, 356.8; ICD10:G64, G90.0] | Investigative | [543878] | ||
Company |
MD Anderson Cancer Center
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H23N3O2
|
||||
Canonical SMILES |
C\1(=N/NC(=O)c2ccccc2)/C(=O)N(c2c1cccc2)CCCCCC
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Agonist | [543878] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.